Keyphrases
Prospective Evaluation
100%
Heart Failure Trials
100%
VO2peak
100%
Elastic Restraint
100%
Heart Failure Patients
75%
Left Ventricular Remodeling
75%
All-cause Mortality
50%
Quality of Life
50%
Left Ventricular End-diastolic Diameter
50%
Optimal Medical Therapy
50%
6-minute Walk Distance (6MWD)
50%
Interim Analysis
50%
Minnesota Living with Heart Failure
50%
Prospective Randomized Trial
25%
Multicenter Trial
25%
Quality of Life Assessment
25%
Support System
25%
Poor Outcome
25%
Device Therapy
25%
Left Ventricular Ejection Fraction
25%
Success Rate
25%
Symptomatic Heart Failure
25%
Control Subjects
25%
Between-group
25%
Treatment Group
25%
Outcome Quality
25%
Restraint System
25%
Functional Capacity
25%
Left Ventricular Mass
25%
6-month Follow-up
25%
Kansas City Cardiomyopathy Questionnaire
25%
Responder Rate
25%
Primary Safety
25%
Device Safety
25%
Trial Enrollment
25%
Left Ventricular End-diastolic Volume (LVEDV)
25%
Ventricular Support
25%
Medicine and Dentistry
Congestive Heart Failure
100%
Quality of Life
42%
Heart Ventricle Remodeling
42%
Combination Therapy
28%
All Cause Mortality
28%
Interim Analysis
28%
Myocardial Disease
14%
Heart Left Ventricle Ejection Fraction
14%
Functional Status
14%
Device Therapy
14%
End-Diastolic Volume
14%
Treatment Group
14%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Heart Ventricle Remodeling
42%
All Cause Mortality
28%
Functional Status
14%
Myocardial Disease
14%
Combination Therapy
14%
Treatment Group
14%